Growing demand for gastroretentive drug delivery systems in emerging economies creates opportunities in the market


The Gastroretentive Drug Delivery Systems market is expected to grow significantly in the coming years. Gastroretentive drug delivery systems are designed to improve drug bioavailability, reduce drug waste, and provide targeted drug delivery to the site of action in the gastrointestinal tract. These systems offer several benefits such as increased drug efficacy, reduced dosing frequency, improved patient compliance, and reduced side effects.

The growing demand for gastroretentive drug delivery systems is driving market growth. Factors such as increasing prevalence of gastrointestinal disorders, growing geriatric population, rising demand for targeted drug delivery, and technological advancements in drug delivery systems are driving market growth. In addition, the development of new drug delivery systems, such as floating drug delivery systems, bioadhesive drug delivery systems, and expandable gastroretentive drug delivery systems, is expected to further drive market growth.

North America is expected to dominate the gastroretentive drug delivery systems market, followed by Europe and the Asia Pacific. The high prevalence of gastrointestinal disorders and favorable reimbursement policies are some of the factors driving market growth in North America. The Asia Pacific region is expected to grow at a significant pace, driven by factors such as increasing healthcare expenditure, growing awareness about the benefits of gastroretentive drug delivery systems, and the presence of a large patient pool.

Overall, the gastroretentive drug delivery systems market is expected to continue to grow in the coming years, driven by the growing demand for targeted drug delivery, increasing prevalence of gastrointestinal disorders, and technological advancements in drug delivery systems.

Request a sample Report of Gastroretentive Drug Delivery Systems Market @

The gastroretentive drug delivery systems market is composed of various segments and several companies operating within each segment. Here are some key segments and notable companies in the gastroretentive drug delivery systems market:

  1. Floating Drug Delivery Systems (FDDS):
    • Adare Pharmaceuticals
    • Ashland Global Holdings Inc.
    • Colorcon Inc.
    • Evonik Industries AG
    • Gattefossé
    • Shin-Etsu Chemical Co., Ltd.
  2. Mucoadhesive Drug Delivery Systems:
    • Novartis International AG
    • Ferring Pharmaceuticals
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Procter & Gamble
    • Sanofi S.A.
  3. Swellable and Expandable Systems:
    • Janssen Pharmaceuticals, Inc.
    • AstraZeneca plc
    • Takeda Pharmaceutical Company Limited
    • Bristol Myers Squibb Company
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
  4. Shape Memory Systems:
    • Merck KGaA
    • Catalent, Inc.
    • Enzychem Lifesciences Corporation
    • Acino International AG
    • Microchips Biotech, Inc.
    • Calypso Biotech S.A.
  5. Magnetic Targeting Systems:
    • EndoMagnetics Ltd.
    • Magnetic Insight, Inc.
    • Medi-Globe GmbH
    • Boston Scientific Corporation
    • Xeris Pharmaceuticals, Inc.
    • AMAG Pharmaceuticals, Inc.
  6. Intrinsic Gastric Retention Systems:
    • Intellipharmaceutics International Inc.
    • Roche Holding AG
    • 3M Company
    • Camurus AB
    • BioDelivery Sciences International, Inc.
    • Macrocure Ltd.
  7. Smart or Responsive Drug Delivery Systems:
    • Johnson & Johnson
    • Novo Nordisk A/S
    • Eli Lilly and Company
    • Baxter International Inc.
    • Intuity Medical, Inc.
    • Nemaura Medical Inc.

These are just a few examples of companies and segments within the gastroretentive drug delivery systems market. The market is dynamic and evolving, with new technologies and players entering the field. The presence of companies in specific segments may vary based on their product portfolios, research focus, and market strategies.

Browse Full Report Description with Research Methodology, Table of Content, and Infographics @

The gastroretentive drug delivery systems market has seen several innovations aimed at improving drug delivery, enhancing patient compliance, and optimizing therapeutic outcomes. Here are some notable innovations in this field:

  1. Floating Drug Delivery Systems (FDDS): FDDS are designed to float and remain in the stomach for an extended period, allowing sustained drug release and prolonged drug exposure to the target site. These systems typically utilize buoyant materials or gas-generating agents to maintain buoyancy. FDDS offer improved bioavailability, reduced dosing frequency, and enhanced therapeutic efficacy for drugs with a narrow absorption window.
  2. Mucoadhesive Drug Delivery Systems: Mucoadhesive systems are designed to adhere to the gastric mucosa, prolonging gastric residence time and facilitating controlled drug release. These systems utilize polymers or bioadhesive materials that interact with the mucus layer or mucosal tissues, enabling sustained drug delivery. Mucoadhesive drug delivery systems enhance drug absorption, reduce systemic side effects, and improve therapeutic outcomes.
  3. Swellable and Expandable Systems: Swellable or expandable drug delivery systems are designed to swell or expand upon contact with gastric fluids, forming a larger and more cohesive mass. This helps retain the dosage form within the stomach, prolonging drug release and absorption. Swellable and expandable systems provide controlled drug delivery, minimize drug waste, and improve patient compliance.
  4. Shape Memory Systems: Shape memory systems are stimuli-responsive drug delivery systems that change their shape or configuration in response to environmental cues, such as temperature or pH changes. These systems can be designed to collapse or transform into a different shape, allowing them to adapt to the gastric environment and prolong gastric retention. Shape memory systems offer customized drug release profiles, improved therapeutic efficacy, and ease of administration.
  5. Magnetic Targeting Systems: Magnetic targeting systems utilize magnetic materials or nanoparticles incorporated into the drug delivery system to enable site-specific drug delivery within the gastrointestinal tract. External magnetic fields are applied to guide and retain the dosage form in the desired location, such as the stomach. Magnetic targeting systems improve drug localization, reduce systemic side effects, and enhance therapeutic outcomes.
  6. Intrinsic Gastric Retention Systems: Intrinsic gastric retention systems are designed to take advantage of the stomach’s natural anatomy and physiology to prolong drug residence time. These systems utilize geometric shapes, size enlargement upon hydration, or specific design features to retain the dosage form within the stomach. Intrinsic gastric retention systems offer controlled drug release, reduce dosing frequency, and enhance patient adherence.
  7. Smart or Responsive Drug Delivery Systems: Smart drug delivery systems are designed to respond to specific stimuli, such as pH, enzymes, or other physiological factors, to trigger drug release at the desired site. These systems can provide targeted drug delivery, improved therapeutic efficacy, and reduced systemic side effects by selectively releasing drugs in response to disease-specific conditions.

These innovations in gastroretentive drug delivery systems offer potential advantages in terms of drug release kinetics, bioavailability, patient compliance, and therapeutic outcomes. They contribute to the development of more effective and patient-friendly drug delivery options for various gastrointestinal diseases and conditions.

Request customization of the report @

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report. 

Explore More Industry Research by Reports and Data:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W,

Head of Business Development

Reports And Data | Web:

Direct Line: +1-212-710-1370


LinkedIn | Twitter | Blogs

Read the innovative blog at

Check out our upcoming research report at

Browse More Reports:

Cell and Tissue Preservation Market

Diabetes Insulin Pen Market

Infant Incubator Market

Glanders Market

Zinc Pyrithione Market